[Corrigendum] 7‑Difluoromethoxyl‑5,4'‑di‑n‑octyl genistein inhibits the stem‑like characteristics of gastric cancer stem‑like cells and reverses the phenotype of epithelial‑mesenchymal transition in gastric cancer cells

Cao,Xiaozheng; Ren,Kaiqun; Song,Zhengwei; Li,Duo; Quan,Meifang; Zheng,Yu; Cao,Jianguo; Zeng,Wenbin; Zou,Hui

doi:10.3892/or.2022.8391

October-2022 Volume 48 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October-2022 Volume 48 Issue 4

Full Size Image

Correction Open Access

[Corrigendum] 7‑Difluoromethoxyl‑5,4'‑di‑n‑octyl genistein inhibits the stem‑like characteristics of gastric cancer stem‑like cells and reverses the phenotype of epithelial‑mesenchymal transition in gastric cancer cells

Authors:
- Xiaozheng Cao
- Kaiqun Ren
- Zhengwei Song
- Duo Li
- Meifang Quan
- Yu Zheng
- Jianguo Cao
- Wenbin Zeng
- Hui Zou
View Affiliations / Copyright

Affiliations: Medical College, Hunan Normal University, Changsha, Hunan 410013, P.R. China, School of Pharmaceutical Sciences and Molecular Imaging Research Center, Central South University, Changsha, Hunan 410013, P.R. China

Copyright: © Cao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 176
|
Published online on: August 22, 2022

https://doi.org/10.3892/or.2022.8391
Expand metrics +

Article

Oncol Rep 36: [Related article:] 1157–1165, 2016; DOI: 10.3892/or.2016.4848

Subsequently to the publication of the above article, an interested reader drew to the authors' attention that there appeared to be two pairs of images in Fig. 2A and B on p. 1159 and Fig. 4 on p. 1161 that contained overlapping sections, such that these figures, which were intending to show the results from differently performed experiments, may have been derived from the same original sources.

Figure 4.

Inhibition of sphere-forming ability by DFOG in gastric cancer stem-like cells (GCSLCs) from SGC-7901 cells and the statistical analysis. *P<0.05 vs. the group treated with 0.1% DMSO; **P<0.01 vs. the group treated with 0.1% DMSO; ***P<0.001 vs. the group treated with 0.1% DMSO; #P<0.05 vs. the group treated with 1.0 µmol/l DFOG.

The authors have examined their original data, and realize that, although Fig. 2 was correct as presented in the article, these data were erroneously and inadvertently included in Fig. 4. The revised version of Fig. 4, which shows the inhibition of sphere-forming ability by 7-difluoromethoxyl-5,4′-di-n-octyl genistein (DOFG) in gastric cancer stem-like cells derived from SGC-7901 cells, is shown below, now including the correct data for the panels showing treatment with 0 and 1.0 µmol/l DOFG, and with re-quantification of these data. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish a Corrigendum, and all the authors agree with its publication. Furthermore, they apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] 7‑Difluoromethoxyl‑5,4'‑di‑n‑octyl genistein inhibits the stem‑like characteristics of gastric cancer stem‑like cells and reverses the phenotype of epithelial‑mesenchymal transition in gastric cancer cells

This article is mentioned in:

Article

Figure 4.

Related Articles